HAVN Life Sciences Inc.
HAVLF · OTC
1/31/2023 | 10/31/2022 | 7/31/2022 | 4/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$692 | $250 | -$3,903 | -$11,367 |
| Dep. & Amort. | $0 | -$23 | $46 | $165 |
| Deferred Tax | $77 | $1,297 | $0 | $9,690 |
| Stock-Based Comp. | $60 | $276 | -$114 | $177 |
| Change in WC | $813 | $179 | $133 | -$205 |
| Other Non-Cash | $32 | -$2,537 | $2,948 | $90 |
| Operating Cash Flow | $289 | -$558 | -$891 | -$1,450 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $28 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $28 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$284 | $0 | -$33 | -$33 |
| Stock Issued | $0 | $0 | $0 | $2,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $454 | -$20 | -$334 |
| Financing Cash Flow | -$284 | $454 | -$53 | $1,633 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5 | -$104 | -$943 | $211 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9 | $112 | $1,056 | $845 |
| End Cash | $14 | $9 | $112 | $1,056 |
| Free Cash Flow | $289 | -$558 | -$891 | -$1,450 |